• What are
  FAVORITES?
  Bookmark any page of our site conveniently in this one area.
  
  Sign In or Register so you can take advantage of all of the features of After Fifty Living

The U.S. Food and Drug Administration has approved Asclera (polidocanol) injection for the treatment of small types of abnormally swollen or twisted veins called varicose veins.

Although they usually occur in the legs, varicose veins also can form in other parts of the body. Factors such as genetics, age, female gender, pregnancy, obesity, and prolonged periods of standing may increase the risk for varicose veins.

"Varicose veins are a common condition," said Norman Stockbridge, M.D., Ph.D., director of the Division of Cardiovascular and Renal Products at the FDA's Center for Drug Evaluation and Research. "Asclera is indicated for the treatment of small types of varicose veins when the aim of treatment is to improve appearance."

Asclera is approved to close spider veins (tiny varicose veins less than 1 millimeter in diameter) and reticular veins (those that are 1 to 3 millimeters in diameter). Asclera acts by damaging the cell lining of blood vessels. This causes the blood vessel to close, and it is eventually replaced by other types of tissue.

Common adverse reactions to Asclera include leakage and collection of blood from damaged blood vessels at the injection site (hematoma), bruising, irritation, discoloration, and pain at the injection site.

Asclera is distributed by BioForm Medical Inc. of Franksville, Wis., and manufactured by Chemische Fabrik Kreussler & Co. of Wiesbaden, Germany.

For more information: 
National Heart Lung and Blood Institute - 
What are Varicose Veins?   
http://www.nhlbi.nih.gov/health/dci/Diseases/vv/vv_all.html 
Consumer inquiries: 888-INFO-FDA  

U.S. Food and Drug Administration

CONTACT: Sandy Walsh of the U.S. Food and Drug Administration,+1-301-796-4669, sandy.walsh@fda.hhs.gov  

Leave a Comment -

Guidelines: We welcome your thoughts, but for the sake of all visitors to AfterFiftyLiving.com, please refrain from the use of obscenities, personal attacks or slurs. All comments are subject to our terms of use and may be removed. Repeat offenders may lose commenting privileges.